# Madrigal Pharmaceuticals, Inc. (MDGL) — Net Income

## Annual Net Income (USD)

| Year | Net Income |
| --- | --- |
| 2025 | -$288M |
| 2024 | -$466M |
| 2023 | -$374M |
| 2022 | -$295M |
| 2021 | -$242M |
| 2020 | -$202M |
| 2019 | -$84M |
| 2018 | -$33M |
| 2017 | -$31M |

## Quarterly Net Income (USD)

| Quarter | Net Income |
| --- | --- |
| 2026-03-31 | -$94M |
| 2025-09-30 | -$114M |
| 2025-06-30 | -$42M |
| 2025-03-31 | -$73M |
| 2024-09-30 | -$107M |
| 2024-06-30 | -$152M |
| 2024-03-31 | -$148M |
| 2023-09-30 | -$99M |
| 2023-06-30 | -$86M |
| 2023-03-31 | -$77M |
| 2022-03-31 | -$58M |
| 2021-09-30 | -$63M |
| 2021-06-30 | -$62M |
| 2021-03-31 | -$53M |
| 2020-09-30 | -$58M |
| 2020-06-30 | -$49M |
| 2020-03-31 | -$36M |
| 2019-09-30 | -$21M |
| 2019-06-30 | -$20M |
| 2019-03-31 | -$15M |
| 2018-03-31 | -$6M |

Source: [CompaniesByCap](https://companiesbycap.com/company/MDGL/net-income)